I think you owe it to put something like that up there or change the charter or get us to change it.
On the recordNovember 29, 2016
Source
congress.govEditor's note · Context
Collins emphasizes the need for transparency regarding the Task Force's cost considerations.
Share & report
More from Chris Collins
May 16, 2016
I'm concerned about--I have a very rural area--access and it's exactly what we're seeing, that the private practices are being bought up for one sole purpose and that's so the DSH hospitals can cheat.
May 16, 2016
if there's a problem in the cost of drugs and cancer drugs, it's all the private oncology practices being purchased by hospital systems--DSH hospitals who then get a 50 percent break from the pharmaceutical companies on these expensive…
May 16, 2016
I guess I kind of reject that because under the higher cost you're getting $25.40. Under the lower one you're getting $21.10. I don't think either one is adequate.





